Delivery Order SPE2DB22D1106-SPE2DB25FFGN5
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for Vyvanse 20 mg capsules (100 count) with a ceiling value of $9,282.09. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,376.94 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Vyvanse 60 mg capsules. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 17, 2025, and will be performed at the company's Conshohocken facility. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Vyvanse 60 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $1,946.30. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by April 25, 2025. This delivery order represents a continuation of AmerisourceBergen's role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,904.90 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, for the supply of Vyvanse 30 milligram capsules (100 count). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside designation. This award falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, valued at $6,880.66 for 100 capsules of Vyvanse 20 mg. This contract is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award is part of the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Vyvanse 40 mg capsules (100-count packages) valued at $1,185.78. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 12, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,783.60 on May 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) by the Defense Logistics Agency. This contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement with an ultimate completion date of May 14, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 6, 2025, for Vyvanse 40 mg capsules (100-count units) valued at $4,250.18. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $6,688.50. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $1,783.60. This firm fixed price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...